Adial Pharmaceuticals, Inc. (ADIL) ownership: Top institutional holder: ARMISTICE CAPITAL, LLC ($561977.00). Insider activity: Net Seller (5 buys, 15 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 2554442.00 | $561977.00 | 2025-12-31 |
| CITADEL ADVISORS LLC | 219621.00 | $48317.00 | 2025-12-31 |
| RENAISSANCE TECHNOLOGIES LLC | 47613.00 | $48089.00 | 2024-12-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 24249.00 | $43405.00 | 2026-03-31 |
| VANGUARD GROUP INC | 156024.00 | $34325.00 | 2025-12-31 |
| JANE STREET GROUP, LLC | 121841.00 | $26805.00 | 2025-12-31 |
| NORTHERN TRUST CORP | 65979.00 | $14515.00 | 2025-12-31 |
| Virtu Financial LLC | 63827.00 | $14000.00 | 2025-12-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Buy | null | 2026-07-14 | |
| Buy | null | 2026-07-14 | |
| Buy | null | 2026-07-09 | |
| Buy | null | 2026-07-09 | |
| Buy | null | 2026-06-29 | |
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 |
Back to ADIL overview · ADIL earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.